Skip to main content

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Study of the Main Molecular Pathways Activating Brachiury in Chordomas (PDGFR, EGFR, FGFR and Wnt)

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: -
Funding agency: GRUPO ESPAÑOL INVESTIGACIÓN SARCOMAS (GEIS)
Funding: 8000
Reference: GEIS/BRACHURY/2016/CLEOFÉ
Duration: 06/06/2016 - 05/06/2019

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Estandarización del diagnóstico anatomopatológico y por imagen de los cambios de transformación maligna inicial en neurofibromas de pacientes con Neurofibromatosis tipo 1

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: Jordi Temprana Salvador, Jorge Pérez López, Marc Simo Perdigo, Claudia Maria Valverde Morales
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI14/00724
Duration: 01/01/2015 - 31/12/2018

Estudi sobre la viabilitat de l'anastomosi vascular microquirúrgica en població irradiada. Estudi en model animal en rata.

IP: Roberto Vélez Villa
Collaborators: Cleofé Romagosa Pérez-Portabell, César Galo García Fontecha, Manuel Llusà Pérez, Francisco Soldado Carrera, David Barastegui Fernández
Funding agency: SOCIETAT CATALANA DE CIRURGIA
Funding: 12000
Reference: SCCOT-2012-01
Duration: 01/11/2012 - 31/10/2013

Related news

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Leire Sanchez Corujo

Leire Sanchez Corujo

Predoctoral researcher
General Surgery
Read more
Estevo Santamarina Pérez

Estevo Santamarina Pérez

Head of group
Research Group on Status Epilepticus and Acute Seizures
Read more
Tamara Jimenez Martin

Tamara Jimenez Martin

Clinical Research Development Directorate
Read more
Karla Alejandra  Cameron  Veas

Karla Alejandra Cameron Veas

Tècnic de recerca
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.